Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.

Nature neuroscience·2026
Same author

Design of Neuronal Supramolecular Scaffolds Integrating Cell Signaling and Electrical Conductivity.

ACS biomaterials science & engineering·2026
Same author

Peptide-Induced Ferroelectricity in Charge-Transfer Supramolecular Materials.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A role for the cholinergic neuron circadian clock in RNA metabolism and mediating neurodegeneration.

Life science alliance·2025
Same author

TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS.

Neuron·2025
Same author

Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency.

Nature communications·2025
Same journal

Daily briefing: How cooperation built the world.

Nature·2026
Same journal

Deep-sea oddities and boatloads of other new species - June's best science images.

Nature·2026
Same journal

From cloning to gene-editing: the enduring legacy of Dolly the sheep.

Nature·2026
Same journal

Time to give hydration breaks the red card? What science says about keeping cool.

Nature·2026
Same journal

Universities are relying on AI-detection software to catch cheating. How well do the programs work?

Nature·2026
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 4, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

Mutaciones somáticas codificantes en células madre pluripotentes inducidas por humanos.

Athurva Gore1, Zhe Li, Ho-Lim Fung

  • 1Department of Bioengineering, University of California at San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.

Nature
|March 4, 2011
PubMed
Resumen
Este resumen es generado por máquina.

Las células madre pluripotentes inducidas (hiPS) pueden adquirir mutaciones genéticas durante la reprogramación. Estas modificaciones genéticas adquiridas, junto con los cambios epigenéticos, requieren un cribado genético para aplicaciones clínicas seguras.

Más Videos Relacionados

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
08:36

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes

Published on: August 20, 2015

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP
08:25

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP

Published on: April 3, 2012

Videos de Experimentos Relacionados

Last Updated: Jun 4, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
08:36

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes

Published on: August 20, 2015

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP
08:25

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells (iPSCs) Using Retroviral Vector with GFP

Published on: April 3, 2012

Área de la Ciencia:

  • Biología celular Biología celular.
  • Genética La genética.
  • Investigación con células madre.

Sus antecedentes:

  • Los factores de transcripción definidos pueden reprogramar epigenéticamente las células de mamíferos adultos en células madre pluripotentes inducidas (hiPS).
  • La integridad genómica a nivel de un solo nucleótido después de la reprogramación sigue siendo en gran medida no caracterizada.

Objetivo del estudio:

  • Investigar si las células madre pluripotentes inducidas (hiPS) adquieren modificaciones genéticas durante el proceso de reprogramación.
  • Evaluar la naturaleza y la frecuencia de las mutaciones puntuales en las líneas celulares hiPS generadas por diferentes métodos.

Principales métodos:

  • Secuenciación de 22 líneas celulares madre pluripotentes inducidas por humanos (hiPS) generadas utilizando cinco métodos de reprogramación distintos.
  • Análisis de las regiones codificantes de proteínas para mutaciones puntuales, incluidas las variantes no sinónimas, sin sentido y de empalme.
  • Comparación de mutaciones en células hiPS con sus células progenitoras de fibroblastos originales.

Principales resultados:

  • Se identificaron un promedio de cinco mutaciones puntuales codificantes de proteínas por exoma en líneas celulares hiPS.
  • Las mutaciones se enriquecieron en genes asociados con el cáncer.
  • Aproximadamente la mitad de las mutaciones observadas preexistían en las células progenitoras, mientras que el resto surgió durante o después de la reprogramación.

Conclusiones:

  • Las células madre pluripotentes inducidas por humanos (hiPS) adquieren mutaciones genéticas además de la reprogramación epigenética.
  • Estas alteraciones genéticas pueden incluir variantes potencialmente dañinas en los genes asociados con el cáncer.
  • La detección genética integral es crucial para garantizar la seguridad de las células hiPS antes del uso clínico.